We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Category-Defining Balloon Distal Access Catheter Allows Surgeons to Get Much Closer to Blood Clots

By HospiMedica International staff writers
Posted on 08 Feb 2023
Print article
Image: The Vena BDAC provides a superior solution to distal navigation (Photo courtesy of Vena Medical)
Image: The Vena BDAC provides a superior solution to distal navigation (Photo courtesy of Vena Medical)

Thrombectomy is a minimally invasive procedure for removing a blood clot and has now become standard of care treatment for patients with an acute ischemic stroke (AIS) secondary to a Large Vessel Occlusion (LVO). Surgeons use several available techniques, all of which aim to restore blood flow at the earliest. Now, a new device combines the balloon guide catheters and distal access catheters currently used in thrombectomy to remove clots from the brains of stroke victims, allowing clinicians to get the balloon much closer to the clot.

Vena Medical’s (Kitchener, ON, Canada) Vena Balloon Distal Access Catheter (BDAC) is a category-defining device that combines both a distal access catheter and balloon guide catheter to bring the balloon closer to the clot and stop residual clots in their tracks. Studies have shown that getting the balloon much closer to the clot improves key metrics such as First Pass Success Rate, enabling the removal of the clot in the first attempt and resulting in significantly better patient outcomes. Vena BDAC allows the use of manual aspiration to increase first pass effect, remove residual clots and reduce costs. It also reduces the number of devices to treat each patient and consequently, the cost of the procedure. The first five patients in the world have now been successfully treated using the Vena BDAC at Canadian hospitals.

“We’re proud to have the first patients to benefit from our Canadian developed technology within driving distance of our office, in the hands of world-class physicians. This is cutting-edge technology that would normally need to be launched somewhere far from here, but we’re excited to make an impact locally before we make an impact globally” said Michael Phillips, the CEO of Vena Medical.

Related Links:
Vena Medical 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Video Laryngoscope
SH-VL1

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more